Virtual Rehabilitation in Parkinson Disease A Dopamine Transporter Imaging Study

被引:5
|
作者
Toldo, Juliana M. P. [1 ]
Arjona, Michelly [1 ]
Campos Neto, Guilherme C. [1 ]
Vitor, Taise [1 ]
Nogueira, Solange Amorim [1 ]
Amaro, Edson, Jr. [1 ]
Saba, Roberta A. [2 ,3 ]
Silva, Sonia M. C. A. [2 ,3 ]
Ferraz, Henrique B. [3 ]
Felicio, Andre C. [1 ]
机构
[1] Hosp Israelita Albert Einstein, Sao Paulo, Brazil
[2] Inst Assistencia Med Servidor Publ Estadual Sao P, Sao Paulo, Brazil
[3] Univ Fed Sao Paulo, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Parkinson Disease; Virtual Rehabilitation; Dopamine Transporter; SPECT; TC-99M-TRODAT-1; SPECT; STRIATAL DOPAMINE; BALANCE; MOTOR; EXERCISE; ATTENTION; DEFICITS; REALITY; GAIT;
D O I
10.1097/PHM.0000000000001574
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective The aim of the study was to verify the effect of a virtual rehabilitation protocol for patients with Parkinson disease, primarily assessing striatal dopamine transporters and secondarily motor symptoms and quality of life. Design Nineteen patients with Parkinson disease underwent an 8-wk virtual rehabilitation protocol using XBOX 360S. Evaluation of dopamine transporters was performed by single-photon emission computed tomography using TRODAT-1 as the radioligand. Participants were clinically assessed using the Unified Parkinson Disease Rating Scale to quantify motor symptoms. Moreover, the Parkinson Disease Questionnaire and Short-Form Health Status Survey were used to assess quality of life and the Berg Balance Scale to assess balance. Results Regarding our primary outcome, dopamine transporter was significantly increased in the putamen contralateral to the clinically most affected body side (P = 0.034) considering preintervention and postintervention measurements. Furthermore, we observed significant improvement in Unified Parkinson Disease Rating Scale (10-point reduction, P = 0.001), Parkinson Disease Questionnaire (11.3-point reduction, P = 0.001), Short-Form Health Status Survey ("Functional capacity," P = 0.001; "Pain," P = 0.006; and "Mental Health" domains, P < 0.001), and Berg Balance Scale (5-point increase, P = 0.015). Conclusions In our group of Parkinson disease patients, this virtual rehabilitation protocol enabled a dopamine transporter increase in the region of the putamen contralateral to the clinically most affected body side. Moreover, motor signs and quality of life were significantly improved.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 50 条
  • [1] Study of the prevalence of Parkinson's disease using dopamine transporter imaging
    Kim, J. S.
    Kim, J. M.
    Kim, K. W.
    Kim, Y. K.
    Kim, S. E.
    Jeon, B. S.
    MOVEMENT DISORDERS, 2009, 24 : S125 - S125
  • [2] Study of the prevalence of Parkinson's disease using dopamine transporter imaging
    Kim, Jong-Min
    Kim, Ji Seon
    Kim, Ki Woong
    Lee, Seok Bum
    Park, Joon Hyuk
    Lee, Jung Jae
    Kim, Yu Kyeong
    Kim, Sang Eun
    Jeon, Beom S.
    NEUROLOGICAL RESEARCH, 2010, 32 (08) : 845 - 851
  • [3] Dopamine Transporter SPECT Imaging in Parkinson Disease and Dementia
    Surasi, Devaki Shilpa
    Peller, Patrick J.
    Szabo, Zsolt
    Mercier, Gustavo
    Subramaniam, Rathan M.
    PET CLINICS, 2013, 8 (04) : 459 - +
  • [4] The Research of Dopamine Transporter Imaging of Patients with Parkinson's Disease
    Bao, S. Y.
    Luo, W. F.
    Wu, J. C.
    JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (01) : 65 - 65
  • [5] The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease
    Ahlskog, JE
    Uitti, RJ
    O'Connor, MK
    Maraganore, DM
    Matsumoto, JY
    Stark, KF
    Turk, MF
    Burnett, OL
    MOVEMENT DISORDERS, 1999, 14 (06) : 940 - 946
  • [6] Dopamine transporter imaging with β-CIT and SPECT in Parkinson's disease
    Martin, W
    Mercer, J
    Hodder, J
    McEwan, S
    NEUROLOGY, 1998, 50 (04) : A390 - A390
  • [7] Dopamine transporter (DAT) imaging in Parkinson’s disease and related disorders
    Thomas Brücke
    Christof Brücke
    Journal of Neural Transmission, 2022, 129 : 581 - 594
  • [8] Dopamine Transporter Imaging as Monitoring Biomarker in Parkinson's disease (PD)
    van Eimeren, T.
    Dzialas, V.
    Bischof, G.
    Moellenhoff, K.
    Drzezga, A.
    MOVEMENT DISORDERS, 2024, 39 : S476 - S476
  • [9] PARKINSON DISEASE Can dopamine transporter imaging define early PD?
    Antonini, Angelo
    Biundo, Roberta
    NATURE REVIEWS NEUROLOGY, 2014, 10 (08) : 432 - 433
  • [10] Development of dopamine transporter imaging agents for the diagnosis of Parkinson's disease
    Morgan, GF
    Nowotnik, DP
    DRUG NEWS & PERSPECTIVES, 1999, 12 (03) : 137 - 145